Several resistance mutations have even been proposed within the same patient or tumor, which substantially complicates the study of resistance mechanisms.31 Here, using a novel mouse model of melanoma that permits temporal regulation and targeted delivery of genes into somatic cells, we investigated whether MEK mutations, found in resistant melanomas, can drive the development and maintenance of melanoma in vivo. The gene discussed is MAP2K7; the disease is neoplasm.